Prevalence and clinical significance of the genotypic carriage among ESBL phenotype-negative Escherichia coli and Klebsiella pneumoniae clinical isolates in bacteremia: a study in a Malaysian tertiary center.
Chee Lan Lau, Hui-Min Neoh, Petrick Periyasamy, Tg Mohd Ikhwan Tg Abu Bakar Sidik, Toh Leong Tan, Ramliza Ramli, Isa Naina Mohamed
{"title":"Prevalence and clinical significance of the genotypic carriage among ESBL phenotype-negative <i>Escherichia coli</i> and <i>Klebsiella pneumoniae</i> clinical isolates in bacteremia: a study in a Malaysian tertiary center.","authors":"Chee Lan Lau, Hui-Min Neoh, Petrick Periyasamy, Tg Mohd Ikhwan Tg Abu Bakar Sidik, Toh Leong Tan, Ramliza Ramli, Isa Naina Mohamed","doi":"10.3389/fcimb.2024.1429830","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Antimicrobial resistance (AMR) can lead to fatal consequences. AMR genes carriage by phenotypically susceptible bacteria, such as Extended-Spectrum β-Lactamases (ESBL)s in <i>Enterobacteriaceae</i>, have potential implications for AMR spread and therapeutic outcomes. This phenomenon should be investigated.</p><p><strong>Methods: </strong>Positive blood cultures from hospitalized patients in a Malaysian tertiary center between April 2022 and March 2023 were reviewed. A total of 137 clinical isolates of <i>Escherichia coli (E.coli</i>), <i>Klebsiella pneumoniae</i> (<i>K.pneumoniae</i>), and <i>Klebsiella oxytoca</i> were included. The antibiotic susceptibility and ESBL phenotypes were determined by disk diffusion method and the identification of genotypes by multiplex polymerase chain reaction. The clinical characteristics and outcome information were extracted by reviewing patients' medical records to evaluate the clinical significance of the ESBL genotype-positive but phenotype-negative isolates in bacteremia.</p><p><strong>Results: </strong>All 137 isolates were positive for at least one genotype (<i>bla</i> <sub>CTX-M</sub>, n = 71, 51.8%; <i>bla</i> <sub>SHV</sub>, n = 87, 63.5%; <i>bla</i> <sub>TEM</sub>, n = 95, 69.3%; <i>bla</i> <sub>OXA-1</sub>, n = 38, 27.7%). While <i>bla</i> <sub>CTX-M</sub> was proportionately higher in the ESBL phenotype-positive isolates than ESBL phenotype-negative isolates (33/37, 89.2% vs 38/100, 38%; p < 0.001), more than half of those harboring <i>bla</i> <sub>CTX-M</sub> remained susceptible to third-generation cephalosporins (3GC). The sensitivity (Sen) of <i>bla</i> <sub>CTX-M</sub> for ESBL phenotypes prediction was 89.19% (95% confidence interval [CI], 74.58 - 96.97%); however, specificity (Sp) was low (46.47%; 95% CI 39.75 - 53.32). The patient characteristics were similar among 98 ESBL phenotype-negative cases, except that the non-<i>bla</i> <sub>CTX-M</sub> carrier group had significantly more renal impairment (0/37 vs 7/61, p = 0.043) and gastrointestinal sources of bacteremia (9/37 vs 27/61, p = 0.047). No differences were observed in infection severity, in-hospital mortality, and length of stay (LOS) between the <i>bla</i> <sub>CTX-M</sub> and non-<i>bla</i> <sub>CTX-M</sub> carrier groups.</p><p><strong>Conclusion: </strong>The current study provides insight into the gene carriage in <i>E.coli</i> and <i>Klebsiella species</i> clinical isolates, including <i>bla</i> <sub>CTX-M</sub> genotypes in antibiotic-susceptible strains from a Malaysian hospital. The ESBL encoding genotypes such as <i>bla</i> <sub>CTX-M</sub> presented substantially beyond one-third of the ESBL phenotype-negative or 3GC susceptible <i>E.coli</i> and <i>K.pneumoniae</i> isolated from bloodstream infection. Although clinical outcomes were not worsened with <i>bla</i> <sub>CTX-M</sub> genotype-positive but ESBL phenotype-negative isolates in bacteremia, the potential implications for AMR spread deserve further investigation.</p>","PeriodicalId":12458,"journal":{"name":"Frontiers in Cellular and Infection Microbiology","volume":null,"pages":null},"PeriodicalIF":4.6000,"publicationDate":"2024-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11540778/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Cellular and Infection Microbiology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3389/fcimb.2024.1429830","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Antimicrobial resistance (AMR) can lead to fatal consequences. AMR genes carriage by phenotypically susceptible bacteria, such as Extended-Spectrum β-Lactamases (ESBL)s in Enterobacteriaceae, have potential implications for AMR spread and therapeutic outcomes. This phenomenon should be investigated.
Methods: Positive blood cultures from hospitalized patients in a Malaysian tertiary center between April 2022 and March 2023 were reviewed. A total of 137 clinical isolates of Escherichia coli (E.coli), Klebsiella pneumoniae (K.pneumoniae), and Klebsiella oxytoca were included. The antibiotic susceptibility and ESBL phenotypes were determined by disk diffusion method and the identification of genotypes by multiplex polymerase chain reaction. The clinical characteristics and outcome information were extracted by reviewing patients' medical records to evaluate the clinical significance of the ESBL genotype-positive but phenotype-negative isolates in bacteremia.
Results: All 137 isolates were positive for at least one genotype (blaCTX-M, n = 71, 51.8%; blaSHV, n = 87, 63.5%; blaTEM, n = 95, 69.3%; blaOXA-1, n = 38, 27.7%). While blaCTX-M was proportionately higher in the ESBL phenotype-positive isolates than ESBL phenotype-negative isolates (33/37, 89.2% vs 38/100, 38%; p < 0.001), more than half of those harboring blaCTX-M remained susceptible to third-generation cephalosporins (3GC). The sensitivity (Sen) of blaCTX-M for ESBL phenotypes prediction was 89.19% (95% confidence interval [CI], 74.58 - 96.97%); however, specificity (Sp) was low (46.47%; 95% CI 39.75 - 53.32). The patient characteristics were similar among 98 ESBL phenotype-negative cases, except that the non-blaCTX-M carrier group had significantly more renal impairment (0/37 vs 7/61, p = 0.043) and gastrointestinal sources of bacteremia (9/37 vs 27/61, p = 0.047). No differences were observed in infection severity, in-hospital mortality, and length of stay (LOS) between the blaCTX-M and non-blaCTX-M carrier groups.
Conclusion: The current study provides insight into the gene carriage in E.coli and Klebsiella species clinical isolates, including blaCTX-M genotypes in antibiotic-susceptible strains from a Malaysian hospital. The ESBL encoding genotypes such as blaCTX-M presented substantially beyond one-third of the ESBL phenotype-negative or 3GC susceptible E.coli and K.pneumoniae isolated from bloodstream infection. Although clinical outcomes were not worsened with blaCTX-M genotype-positive but ESBL phenotype-negative isolates in bacteremia, the potential implications for AMR spread deserve further investigation.
期刊介绍:
Frontiers in Cellular and Infection Microbiology is a leading specialty journal, publishing rigorously peer-reviewed research across all pathogenic microorganisms and their interaction with their hosts. Chief Editor Yousef Abu Kwaik, University of Louisville is supported by an outstanding Editorial Board of international experts. This multidisciplinary open-access journal is at the forefront of disseminating and communicating scientific knowledge and impactful discoveries to researchers, academics, clinicians and the public worldwide.
Frontiers in Cellular and Infection Microbiology includes research on bacteria, fungi, parasites, viruses, endosymbionts, prions and all microbial pathogens as well as the microbiota and its effect on health and disease in various hosts. The research approaches include molecular microbiology, cellular microbiology, gene regulation, proteomics, signal transduction, pathogenic evolution, genomics, structural biology, and virulence factors as well as model hosts. Areas of research to counteract infectious agents by the host include the host innate and adaptive immune responses as well as metabolic restrictions to various pathogenic microorganisms, vaccine design and development against various pathogenic microorganisms, and the mechanisms of antibiotic resistance and its countermeasures.